Overview

A Study of Macitentan in Children Below 2 Years of Age

Status:
Recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn what happens to macitentan and its active metabolite (aprocitentan) in the body of children aged between 1 month and 2 years.
Phase:
Phase 1
Details
Lead Sponsor:
Actelion
Treatments:
Macitentan